Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City_West China Medical Journal

Authors：

 LIZhi-chao ¹ , WUJia ² ,  HUANGHe ³

1. Department of Day Surgery Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Department of General Practice, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
3. Department of Cardiology;West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

HUANGHe, Email: xhehuang@yahoo.com

Keywords：

Dyslipidemia; Cardiovascular risk; Urban resident; Epidemiology

DOI：

10.7507/1002-0179.20150531

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the prevalence status and characteristics of dyslipidemia and cardiovascular risk factors in urban communities of Chengdu city. Methods By cluster sampling, a population of 994 inhabitants were selected from 14 urban communities in Chengdu city between February and October 2010. We investigated patients between 35-70 years old who lived in the area over 2 years, by using questionnaires survey, physical examination, and laboratory tests. According to the age, the respondents were divided into three groups: young group ( ≤ 44 years old), middle-aged group (45-59 years old) and elderly group ( ≥ 60 years old). We further investigated the major cardiovascular risk factors for hyperlipidemic patients. Results The prevalence of dyslipidemia in Chengdu urban area was 28.47% (283/994), and standardized prevalence rate was 24.65% (male, 24.68%; female, 30.91%). The prevalence rate between male and female had significant diTherence (χ²=4.513, P=0.034). Female elderly group and middle-aged group had a significantly higher prevalence than the young group (P<0.05), while the male prevalence had no statistical diTherences among all age groups (P>0.05). Hypertension was most common in patients with dyslipidemia (male, 50.04%; female, 52.41%) followed by diabetes and coronary heart disease. There was no difference between male and female in the prevalence of dyslipidemia accompanied hypertension, history of stoke and coronary heart disease, abdominal obesity,or obesity (P>0.05). Higher prevalence with smoking and drinking was in male patients (P<0.05). Conclusion The prevalence of dyslipidemia is relatively high in urban communities of Chengdu city. According to the region of hyperlipemia epidemiological characteristics and risk factors, by using comprehensive intervention measures, we can reduce the prevalence of dyslipidemia.

Citation： LIZhi-chao, WUJia, HUANGHe. Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City. West China Medical Journal, 2015, 30(10): 1845-1848. doi: 10.7507/1002-0179.20150531 Copy

1.	國家心血管病中心. 中國心血管病報告2013[M]. 北京:中國大百科全書出版社, 2014:1-86.
2.	Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults[J]. Circulation, 2006, 114(21):2217-2225.
3.	D'Agostino RS, Grundy S, Sullivan LM, et al. Validation of the framingham coronary heart disease prediction scores:results of a multiple ethnic groups investigation[J]. JAMA, 2001, 286(2): 180-187.
4.	武陽豐, 趙冬, 周北凡, 等. 中國成人血脂異常診斷和危險分層方案的研究[J]. 中華心血管病雜志, 2007, 35(5):428-433.
5.	中華心血管雜志編輯委員會. 多重心血管危險因素綜合防治建議[J]. 中華心血管病雜志, 2006, 12(34):1061-1071.
6.	國家"九五"科技攻關課題協作組. 我國中年人群心血管病主要危險因素流行現狀及從80年代初至90年代末的變化趨勢[J]. 中華心血管病雜志, 2001, 29(2):74-79.
7.	中國成人血脂異常防治指南制訂聯合委員會. 中國成人血脂異常防治指南[J]. 中華心血管病雜志, 2007, 35(5):390-419.
8.	Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010[J]. N Engl J Med, 2011, 364(25):2469-2470.
9.	中華醫學會糖尿病學分會. 中國2型糖尿病防治指南(2010年版)[J]. 中國糖尿病雜志, 2012, 20(1):81-117.
10.	陳春明, 國際生命科學學會中國辦事處中國肥胖問題工作組聯合數據匯總分析協作組. 中國成人體質指數分類的推薦意見簡介[J]. 中華預防醫學雜志, 2001, 35(5):349-350.
11.	World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings[M]. Geneva:WHO Library Cataloguing-in-Publication Data:World Health Organization, 2010:17-18.
12.	趙文華, 張堅, 由悅, 等. 中國18歲及以上人群血脂異常流行特點研究[J]. 中華預防醫學雜志, 2005, 39(5):306-310.
13.	He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation, 2004, 110(4): 405-411.
14.	孫瑋, 陳愛芳, 沈宇峰. 上海某中心城區931例社區居民血脂異常情況調查[J]. 健康教育與健康促進, 2014, 9(2):124-126.
15.	莫景富, 宋秀玲, 許燕君, 等. 廣東省成人血脂異常患病率及其危險因素的相關性研究[J]. 華南預防醫學, 2013, 39(2):11-17.
16.	鄧穎, 吳先萍, 高亞禮, 等. 四川城鄉居民血脂異常流行病學分析[J]. 中國慢性病預防與控制, 2006, 14(4):284-285.
17.	藺子, 馬娟珍, 閆香華, 等. 原發性高血壓與血脂、血尿酸的研究進展[J]. 全科護理, 2013, 11(11):1028-1029.
18.	陳金仲, 邵豪. 脂代謝紊亂與胰島素抵抗的相關研究進展[J]. 中國實用醫藥, 2008, 3(7):147-149.
19.	Xi B, Liang YJ, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009[J]. Int J Cardiol, 2012, 158(2):326-329.
20.	Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-958.
21.	戚文威, 黃建鳳, 李建新, 等. 中國人群飲酒與代謝綜合征發病關系的前瞻性研究[J]. 中華健康管理學雜志, 2012, 6(2):75-80.

1. 國家心血管病中心. 中國心血管病報告2013[M]. 北京:中國大百科全書出版社, 2014:1-86.
2. Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults[J]. Circulation, 2006, 114(21):2217-2225.
3. D'Agostino RS, Grundy S, Sullivan LM, et al. Validation of the framingham coronary heart disease prediction scores:results of a multiple ethnic groups investigation[J]. JAMA, 2001, 286(2): 180-187.
4. 武陽豐, 趙冬, 周北凡, 等. 中國成人血脂異常診斷和危險分層方案的研究[J]. 中華心血管病雜志, 2007, 35(5):428-433.
5. 中華心血管雜志編輯委員會. 多重心血管危險因素綜合防治建議[J]. 中華心血管病雜志, 2006, 12(34):1061-1071.
6. 國家"九五"科技攻關課題協作組. 我國中年人群心血管病主要危險因素流行現狀及從80年代初至90年代末的變化趨勢[J]. 中華心血管病雜志, 2001, 29(2):74-79.
7. 中國成人血脂異常防治指南制訂聯合委員會. 中國成人血脂異常防治指南[J]. 中華心血管病雜志, 2007, 35(5):390-419.
8. Li Q, Hsia J, Yang GH. Prevalence of smoking in China in 2010[J]. N Engl J Med, 2011, 364(25):2469-2470.
9. 中華醫學會糖尿病學分會. 中國2型糖尿病防治指南(2010年版)[J]. 中國糖尿病雜志, 2012, 20(1):81-117.
10. 陳春明, 國際生命科學學會中國辦事處中國肥胖問題工作組聯合數據匯總分析協作組. 中國成人體質指數分類的推薦意見簡介[J]. 中華預防醫學雜志, 2001, 35(5):349-350.
11. World Health Organization. Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings[M]. Geneva:WHO Library Cataloguing-in-Publication Data:World Health Organization, 2010:17-18.
12. 趙文華, 張堅, 由悅, 等. 中國18歲及以上人群血脂異常流行特點研究[J]. 中華預防醫學雜志, 2005, 39(5):306-310.
13. He J, Gu D, Reynolds K, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[J]. Circulation, 2004, 110(4): 405-411.
14. 孫瑋, 陳愛芳, 沈宇峰. 上海某中心城區931例社區居民血脂異常情況調查[J]. 健康教育與健康促進, 2014, 9(2):124-126.
15. 莫景富, 宋秀玲, 許燕君, 等. 廣東省成人血脂異常患病率及其危險因素的相關性研究[J]. 華南預防醫學, 2013, 39(2):11-17.
16. 鄧穎, 吳先萍, 高亞禮, 等. 四川城鄉居民血脂異常流行病學分析[J]. 中國慢性病預防與控制, 2006, 14(4):284-285.
17. 藺子, 馬娟珍, 閆香華, 等. 原發性高血壓與血脂、血尿酸的研究進展[J]. 全科護理, 2013, 11(11):1028-1029.
18. 陳金仲, 邵豪. 脂代謝紊亂與胰島素抵抗的相關研究進展[J]. 中國實用醫藥, 2008, 3(7):147-149.
19. Xi B, Liang YJ, Reilly KH, et al. Trends in prevalence, awareness, treatment, and control of hypertension among Chinese adults 1991-2009[J]. Int J Cardiol, 2012, 158(2):326-329.
20. Xu Y, Wang LM, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA, 2013, 310(9):948-958.
21. 戚文威, 黃建鳳, 李建新, 等. 中國人群飲酒與代謝綜合征發病關系的前瞻性研究[J]. 中華健康管理學雜志, 2012, 6(2):75-80.

Previous Article
基于標準化的傷口數據云平臺探討
Next Article
Clinical Analysis of Cranial Venous Sinus Thrombosis

West China Medical Journal

Epidemiological Study of Dyslipidemia with Cardiovascular Risk Factors in Urban Communities of Chengdu City

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content